Your browser doesn't support javascript.
loading
An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains.
D'Ascenzio, Melissa; Pugh, Kathryn M; Konietzny, Rebecca; Berridge, Georgina; Tallant, Cynthia; Hashem, Shaima; Monteiro, Octovia; Thomas, Jason R; Schirle, Markus; Knapp, Stefan; Marsden, Brian; Fedorov, Oleg; Bountra, Chas; Kessler, Benedikt M; Brennan, Paul E.
  • D'Ascenzio M; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
  • Pugh KM; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
  • Konietzny R; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
  • Berridge G; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
  • Tallant C; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
  • Hashem S; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
  • Monteiro O; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
  • Thomas JR; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
  • Schirle M; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
  • Knapp S; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
  • Marsden B; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
  • Fedorov O; Target Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
  • Bountra C; Novartis Institute for BioMedical Research (NIBR), 180 Massachusetts Ave, Cambridge, MA, 02139, USA.
  • Kessler BM; Novartis Institute for BioMedical Research (NIBR), 180 Massachusetts Ave, Cambridge, MA, 02139, USA.
  • Brennan PE; Structural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Angew Chem Int Ed Engl ; 58(4): 1007-1012, 2019 01 21.
Article en En | MEDLINE | ID: mdl-30589164
ABSTRACT
Bromodomain-containing proteins are epigenetic modulators involved in a wide range of cellular processes, from recruitment of transcription factors to pathological disruption of gene regulation and cancer development. Since the druggability of these acetyl-lysine reader domains was established, efforts were made to develop potent and selective inhibitors across the entire family. Here we report the development of a small molecule-based approach to covalently modify recombinant and endogenous bromodomain-containing proteins by targeting a conserved lysine and a tyrosine residue in the variable ZA or BC loops. Moreover, the addition of a reporter tag allowed in-gel visualization and pull-down of the desired bromodomains.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridazinas / Triazoles / Carbamatos / Histonas / Dominios Proteicos / Lisina Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridazinas / Triazoles / Carbamatos / Histonas / Dominios Proteicos / Lisina Idioma: En Año: 2019 Tipo del documento: Article